4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-18-013577
President sold 75,000 shares at $60.00 ($4,500,000)
- President acquired 75,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Novak Rodger President | 2018-05-17 | Option exercise | +35,240 | $1.81 | $63,784 | 1,183,247 | D |
| Novak Rodger President | 2018-05-17 | Option exercise | +39,760 | $14.00 | $556,640 | 1,223,007 | D |
| Novak Rodger President | 2018-05-17 | Sale | −75,000 | $60.00 | $4,500,000 | 1,148,007 | D |
| Derivatives | |||||||
| Novak Rodger President | 2018-05-17 | Option exercise · Stock Option (Right to Buy) | −35,240 | 5,586 | D | ||
| Novak Rodger President | 2018-05-17 | Option exercise · Stock Option (Right to Buy) | −39,760 | 160,240 | D | ||
| Open-market sales · 75,000 sh · avg $60.00 · $4,500,000 | |||||||
Loading xslF345X03/doc4.xml…